Related Experiment Video
Updated: May 23, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Diabetic cardiomyopathy: pathophysiology and clinical features
Takayuki Miki1, Satoshi Yuda, Hidemichi Kouzu
1Division of Cardiology, Second Department of Internal Medicine, School of Medicine, Sapporo Medical University, South-1 West-16, Chuo-ku, Sapporo, 060-8543, Japan.
Insights
Diabetic cardiomyopathy impairs heart function by altering metabolism and cellular signaling. Early detection is possible, but effective prevention and treatment strategies for this common condition remain elusive.
Area of Science:
- Cardiology
- Endocrinology
- Pathophysiology
Background:
- Diabetic cardiomyopathy (DCM) is a distinct cardiac pathology in diabetic patients.
- Diabetes mellitus alters cardiac metabolism, leading to impaired energy production and contractile dysfunction.
- Microvascular changes and extracellular matrix remodeling contribute to DCM pathogenesis.
Purpose of the Study:
- To review current knowledge on the pathogenesis and clinical features of diabetic cardiomyopathy.
- To summarize advancements in early detection methods for DCM.
- To identify unmet needs in the prevention and treatment of diabetic cardiomyopathy.
Main Methods:
- Review of basic and clinical studies on diabetic cardiomyopathy.
- Analysis of metabolic and signaling pathway alterations in the diabetic heart.
- Evaluation of advanced echocardiographic techniques and magnetic resonance spectroscopy for DCM detection.
Main Results:
- Diabetes enhances fatty acid metabolism and suppresses glucose oxidation in the heart.
- Impaired excitation-contraction coupling and increased susceptibility to ischemia/reperfusion injury are key features.
- Sensitive imaging modalities enable early DCM detection and differentiation from other heart diseases.
Conclusions:
- Diabetic cardiomyopathy is a common, often unrecognized condition in asymptomatic diabetic patients.
- Current diagnostic tools allow for early identification of DCM.
- Effective strategies for DCM prevention and treatment are still needed to improve patient outcomes.
Abstract:
Since diabetic cardiomyopathy was first reported four decades ago, substantial information on its pathogenesis and clinical features has accumulated. In the heart, diabetes enhances fatty acid metabolism, suppresses glucose oxidation, and modifies intracellular signaling, leading to impairments in multiple steps of excitation-contraction coupling, inefficient energy production, and increased susceptibility to ischemia/reperfusion injury. Loss of normal microvessels and remodeling of the extracellular matrix are also involved in contractile dysfunction of diabetic hearts. Use of sensitive echocardiographic techniques (tissue Doppler imaging and strain rate imaging) and magnetic resonance spectroscopy enables detection of diabetic cardiomyopathy at an early stage, and a combination of the modalities allows differentiation of this type of cardiomyopathy from other organic heart diseases. Circumstantial evidence to date indicates that diabetic cardiomyopathy is a common but frequently unrecognized pathological process in asymptomatic diabetic patients. However, a strategy for prevention or treatment of diabetic cardiomyopathy to improve its prognosis has not yet been established. Here, we review both basic and clinical studies on diabetic cardiomyopathy and summarize problems remaining to be solved for improving management of this type of cardiomyopathy.
More Related Videos
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Type II Diabetes II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology
Diabetic Ketoacidosis ll: Pathophysiology